Tirath Singh & Bros Agencies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.25 Cr
as on 09-12-2024
About Tirath Singh & Bros Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Viejay Singla and Gurneet Kaur serve as directors at the Company.
- CIN/LLPIN
U24299CH2021PTC043522
- Company No.
043522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2021
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tirath Singh & Bros Agencies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viejay Singla  | Director | 21-Jun-2021 | Current |
| Gurneet Kaur | Director | 21-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Tirath Singh & Bros Agencies.
Tirath Singh & Bros Agencies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tirath Singh & Bros Agencies?
Unlock access to Tirath Singh & Bros Agencies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Singlamedicos Pharma Solutions Private LimitedActive 2 years 8 monthsViejay Singla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Dec 2021 | ₹2.50 M | Satisfied |
Hdfc Bank Limited Creation Date: 28 Jul 2021 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Tirath Singh & Bros Agencies?
Tirath Singh & Bros Agencies has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tirath Singh & Bros Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tirath Singh & Bros Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
